My bookmarksSign up free

2003/2/EC: Commission Decision of 21 November 2001 relating… Article 3

Article 3

For the infringements referred to in Article 1, the following fines are imposed on the following undertakings: (a) F. Hoffmann-La Roche AG: - a fine of EUR 85,5 million for its infringement in the vitamin A market, - a fine of EUR 99,75 million for its infringement in the vitamin E market, - a fine of EUR 42 million for its infringement in the vitamin B2 market, - a fine of EUR 54 million for its infringement in the vitamin B5 market, - a fine of EUR 65,25 million for its infringement in the vitamin C market, - a fine of EUR 21 million for its infringement in the vitamin D3 market, - a fine of EUR 48 million for its infringement in the beta-carotene market, - a fine of EUR 46,5 million for its infringement in the carotinoids market, (b) BASF AG: - a fine of EUR 46,17 million for its infringement in the vitamin A market, - a fine of EUR 89,78 million for its infringement in the vitamin E market, - a fine of EUR 18,9 million for its infringement in the vitamin B2 market, - a fine of EUR 34,02 million for its infringement in the vitamin B5 market, - a fine of EUR 14,68 million for its infringement in the vitamin C market, - a fine of EUR 7,56 million for its infringement in the vitamin D3 market, - a fine of EUR 43,2 million for its infringement in the beta-carotene market, - a fine of EUR 41,85 million for its infringement in the carotinoids market, (c) Aventis SA: a fine of EUR 5,04 million for its infringement in the vitamin D3 market; (d) Takeda Chemical Industries Ltd: - a fine of EUR 8,78 million for its infringement in the vitamin B2 market, - a fine of EUR 28,28 million for its infringement in the vitamin C market; (e) Merck KgaA: a fine of EUR 9,24 million for its infringement in the vitamin C market; (f) Daiichi Pharmaceutical Co. Ltd: a fine of EUR 23,4 million for its infringement in the vitamin B5 market; (g) Solvay Pharmaceuticals BV: a fine of EUR 9,1 million for its infringement in the vitamin D3 market; (h) Eisai Co. Ltd: a fine of EUR 13,23 million for its infringement in the vitamin E market.

Read the full instrument →

Other provisions in 2003/2/EC: Commission Decision of 21 November 2001 relating…

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 3 of 2003/2/EC: Commission Decision of 21 November 2001 relating… (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next